Sushil Suri Proven Great Contributor of Revenue for Morepen Laboratory
Mr. Sushil Suri, science alumna and Chartered Accountant joined Morepen’s Board of Directors from last 10 years. Mr. Sushil Suri has been the cornerstone in the success story of the Morepen Laboratories. At Morepan he is also involved in the day-to-day activities of production, product planning and operations etc. The future growth model of the company will mainly focus on the formulations. Earlier the company was more into bulk drugs. Traditionally all the big brothers started as bulk companies and they slowly turned to formulations. Five years down the line 75% of our sales will be coming from formulations and OTC, whereas 25% of the sales will come from bulk drugs. In formulations our major focus will be on the life style categories. Primarily in the categories of Neuro pschycriatic, cardiac and chest and diabetes where we are launching new products. Another segment that is very popular is gynecology. Gynae is not a new segment. India is the largest producer of kids in the wor...